Search results - 8 results
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
Sensitivity and Specificity Severity of Illness Index triage Uterine Cervical Diseases Uterine Cervical Dysplasia Abstract: BACKGROUND: Women with atypical squamous cells of undetermined significance (ASC- US) ...
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
as Topic Sensitivity and Specificity specimen handling Uterine Cervical Dysplasia Uterine Cervical Neoplasms Vagina Vaginal Smears Abstract: OBJECTIVE: To evaluate the diagnostic accuracy of high-risk ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
Uteri Early Detection of Cancer Female Genotype Genotyping Techniques Humans middle aged Papillomaviridae Papillomavirus Infections Reproducibility of Results Sensitivity and Specificity Slovenia Uterine ...
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Guidelines as Topic Reproducibility of Results Sensitivity and Specificity Uterine Cervical Neoplasms Abstract: BACKGROUND Cervical cancer screening with assays detecting DNA of high-risk human papillomavirus ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
aims to compare the clinical sensitivity and specificity of particular hrHPV assay(s) on vaginal self-samples and first-void-urine, collected in agreement with standardized protocols, with hrHPV testing ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
HC2 (relative sensitivity of 1.01; 95% CI, 0.97⁻1.04; = 0.0002) and a specificity for ≤ CIN1 of 85.3% (95% CI, 83.2⁻87.3%) which was inferior to HC2 (relative specificity of 0.95; 95% CI, 0.93⁻0.97; ...
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
relative sensitivity and specificity compared to Hybrid Capture-2 or GP5 +/6+ PCR –enzyme immunoassay. These latter two hrHPV DNA assays were validated in large randomized trials and cohorts with a follow-up ...
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
Oligonucleotide Probes Papillomaviridae Papillomavirus Infections Reference Standards Sensitivity and Specificity Young adult Abstract: The LMNX genotyping kit HPV GP (LMNX) is based on the clinically validated GP5 ...